Prostate Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Prostate Cancer, including details on symptoms, genetics, screening, treatment, information.

HIF-1alpha promotes survival of prostate cells at a high zinc environment.

Park SE, Park JW, Cho YS, Ryu JH, Paick JS, Chun YS

Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, Korea.

BACKGROUND: The prostate contains extremely high concentrations of zinc, which may be required for male reproduction. Although zinc is essential for many cellular functions, excessive zinc induces cellular toxicity in general. However, despite exposure to high zinc environment, prostate cells survive and proliferate. Thus, the aim of this study was to identify the intrinsic molecular species that endow prostate cells with the ability to overcome zinc toxicity. METHODS: Immunohistochemistry, histofluorescent zinc staining, Western blot, in vitro binding assay, immunoprecipitation, caspase activity assay, and proteasome activity assay. RESULTS: In rat and human prostates, HIF-1alpha was found to be robustly expressed in epithelial layers containing high zinc levels. Moreover, in cultured prostate cells, HIF-1alpha expression was zinc-dependently induced even under normoxic conditions. Mechanistically, zinc ions inhibited HIF-1-prolyl hydroxylase (PHD) activity, and therefore blocked von Hippel-Lindau tumor suppressor protein (pVHL) binding to HIF-1alpha in vivo and in vitro. The HIF-1alpha stabilization was mediated by oxidative stress induced by zinc ion. Even when prostate cells were treated with high concentrations of zinc ion for extended times, only 10% of cells showed apoptotic death. However, this population of apoptotic cells was increased threefold after HIF-1alpha was knocked-down by siRNA. CONCLUSION: These results suggest that HIF-1alpha functions as an intrinsic defense molecule that enables prostate cells to survive in a zinc-rich environment.

Published 8 October 2007 in Prostate, 67(14): 1514-23.
Full-text of this article is available online (may require subscription).

© 2004-2008 Prostate Cancer Research Today. All Rights Reserved.